Your browser doesn't support javascript.
Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice.
Lee, Tae-Young; Lee, Hansaem; Kim, Nayoung; Jeon, Pyeonghwa; Kim, Jun-Won; Lim, Hee-Young; Yang, Jeong-Sun; Kim, Kyung-Chang; Lee, Joo-Yeon.
  • Lee TY; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Lee H; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Kim N; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Jeon P; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Kim JW; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Lim HY; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Yang JS; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Kim KC; Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Cheongju-si, Chungbuk, Republic of Korea.
  • Lee JY; Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea. Electronic address: ljyljy@nih.go.kr.
Virus Res ; 305: 198563, 2021 11.
Article in English | MEDLINE | ID: covidwho-1415831
ABSTRACT
This study compared the lethality of severe acute respiratory syndrome coronavirus 2 variants belonging to the S, V, L, G, GH, and GR clades using K18-human angiotensin-converting enzyme 2 heterozygous mice. To estimate the 50% lethal dose (LD50) of each variant, increasing viral loads (100-104 plaque-forming units [PFU]) were administered intranasally. Mouse weight and survival were monitored for 14 days. The LD50 of the GH and GR clades was significantly lower than that of other clades at 50 PFU. These findings suggest that the GH and GR clades, which are prevalent worldwide, are more virulent than the other clades.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Viral Load / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Variants Limits: Animals / Humans / Male Language: English Journal: Virus Res Journal subject: Virology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Viral Load / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Variants Limits: Animals / Humans / Male Language: English Journal: Virus Res Journal subject: Virology Year: 2021 Document Type: Article